Artiva Biotherapeutics’ (ARTV) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reissued their buy rating on shares of Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) in a research note released on Wednesday morning,Benzinga reports. The firm currently has a $20.00 target price on the stock. A number of other research analysts have also commented on the stock. Wedbush restated an “outperform” rating and set a […]
HC Wainwright reissued their buy rating on shares of Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) in a research note released on Wednesday morning,Benzinga reports. The firm currently has a $20.00 target price on the stock. A number of other research analysts have also commented on the stock. Wedbush restated an “outperform” rating and set a […]
